Relmada Therapeutics (RLMD) Shares Issued (2012 - 2026)

Relmada Therapeutics (RLMD) has 10 years of Shares Issued data on file, last reported at $160.0 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $160.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $160.0 million (changed N/A YoY), and the FY2025 annual result was $93.6 million, up 37848.92% from the prior year.
• Shares Issued rose to $160.0 million in Q1 2026 per RLMD's latest filing, from $246747.0 in the prior quarter.
• Over five years, Shares Issued peaked at $160.0 million in Q1 2026 and troughed at -$42.0 million in Q3 2022.
• A 3-year average of $26.9 million and a median of $430404.5 in 2022 frame the typical range for Shares Issued.
• On a YoY basis, Shares Issued climbed as much as 92.88% in 2022 and fell as far as 99925.89% in 2022.
• A 3-year view of Shares Issued shows it stood at $560803.0 in 2022, then tumbled by 56.0% to $246747.0 in 2024, then soared by 64743.75% to $160.0 million in 2026.
• Business Quant data shows RLMD's Shares Issued at $160.0 million in Q1 2026, $246747.0 in Q1 2024, and $560803.0 in Q4 2022.